Navigation Links
ABC Releases Monograph on Scientific Research of POM Wonderful(R) Pomegranate Juice
Date:8/12/2008

AUSTIN, Texas, Aug. 12 /PRNewswire/ -- The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful(R) Pomegranate Juice.

The monograph includes summaries of 6 clinical trials, in which POM Wonderful Pomegranate Juice was evaluated for its effects on cardiovascular disease, prostate cancer, and erectile dysfunction. The authors of the monograph further provide information on the active constituents and safety of pomegranate juice, as well as distinguishing characteristics particular to POM Wonderful Pomegranate Juice.

"When ABC approached POM Wonderful about doing a monograph, we thought this was an excellent opportunity to have a well-respected organization conduct a third party review of our research," said Mark Dreher, PhD, vice president of scientific and regulatory affairs for POM Wonderful. "Having a monograph summarize and evaluate our growing body of research is an important part of our ongoing scientific process."

Pomegranates have been traditionally used as a food, medicine, and cultural icon by various civilizations for thousands of years. Its popularity among US consumers, however, is relatively recent.

"In 2002, when we launched POM Wonderful, only 12% of the population even knew what a pomegranate was," said Dr. Dreher. "In 6 years, sales of POM have gone from zero to over $150 million."

Previous publications and monographs from ABC have covered the pharmacological and clinical literature on numerous medicinal herbs. "So far as we can determine, this may be the first monograph ever published that covers the clinical research on a conventional food product," said Mark Blumenthal, founder and executive director of ABC, noting that although historically pomegranate has been used as both a food and as a medicinal plant, most people today consider it a conventional food.

"Six years ago, POM Wonderful created the cat
'/>"/>

SOURCE American Botanical Council
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ProSanos Corporation Releases New Software System to Improve Patient Safety via Surveillance and Analysis of Claims and Electronic Health Records
2. Wellcorps International Releases Breakthrough Multi-Benefit WellCapAM(TM) Activation Complex
3. Providence Service Corporation Releases Second Quarter Results
4. As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM
5. The Latino Commission on AIDS Releases Report on the State of HIV/AIDS in Latino/Hispanic Communities in the United States on the Eve of the International AIDS Conference in Mexico City
6. Imagilys Releases Patiencys, a 3D-animation Movie to Improve Magnetic Resonance Imaging Quality and Safety
7. Posit Science Corporation Releases the Brain Fitness Program Classic(TM) for Mac OS X
8. iCRco Releases Clarity PACS, the Clear Solution for Your Digital Radiology Imaging Needs
9. Global Industry Analysts' Releases a Series of Medical Market Research Reports
10. China Medicine Releases White Paper on Developing Recombinant Aflatoxin-Detoxifizyme
11. The Kitchen Bath Store Releases Newest Design in Walk-In Tubs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Biocide Systems is ... Wrench Advisors as a consultant and partner for ... accounts. , As Wrench Advisors explains on its ... your organization plan and execute programs by leveraging ... channels. Our experience developing joint venture partnerships and ...
(Date:8/20/2014)... 2014 In its latest blog post, ... program that gets clients off to a great start and ... in, is highlighting an important and possibly life-changing – perhaps ... who wants to understand the insidious nature of drug abuse: ... that drug abuse targets a certain socioeconomic group, such as ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The award-winning ... (ACPS), has expanded its presence throughout Houston to a ... Eye Institute and Laser Center building. ACPS plastic surgeon ... step forward for ACPS, which has risen to become ... surgery practices in the state since its establishment in ...
(Date:8/20/2014)... August 20, 2014 Texas Medical Research Associates ... The study will help test the effectiveness of a new ... high cholesterol may be eligible to participate in the study. ... in the blood can lead to cardiovascular disease, the no. ... can help reduce the risk of heart disease and stroke. ...
(Date:8/20/2014)... -- White, straight women are much more likely to ... women, a new study finds. Researchers examined data ... 44, who took part in polls in 2002 and ... Family Growth study. In the first poll, 13 ... for infertility. This ranged from getting advice from doctors ...
Breaking Medicine News(10 mins):Health News:Biocide Systems Announces Partnership with Wrench Advisors 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 3Health News:Aesthetic Center for Plastic Surgery Expands Its Reach in Texas 2Health News:Texas Medical Research Associates Announce New Study 2Health News:White Women More Likely to Seek Fertility Treatment: Report 2
... , TUESDAY, April 17 (HealthDay News) -- A group of ... indicators of your chances of living to age 70 than ... challenge the long-held belief that race or the region of ... how long you may live, according to researchers from Stanford ...
... The increasing globalization of the drug supply ... and diversion of medicines, growth of illegal Internet ... into the supply chain. As pharmaceutical companies, regulatory ... determine the best approaches to securing increasingly complex ...
... Randy Dotinga HealthDay Reporter , TUESDAY, April 17 ... value of proton therapy, an expensive new kind of radiation ... the treatment instead of the standard radiation therapy were more ... There also did not appear to be any extra benefit ...
... SEATTLE Larry Corey, M.D., president and director of Fred ... the American Academy of Arts and Sciences, one of the ... centers. , "I,m extremely honored to be in the same ... science, medicine and the arts," Corey said. "I,m also very ...
... April 17 (HealthDay News) -- New research adds to the ... plaques, the brain-clogging fragments that have been associated with Alzheimer,s ... Berlin, researchers report that they were able to use a ... brains of patients whose Alzheimer,s was confirmed after death. ...
... In an analysis of three different types ... cancer, compared with conformal radiation therapy, intensity-modulated radiation ... gastrointestinal adverse effects, hip fractures, and receipt of ... proton therapy was associated with more gastrointestinal adverse ...
Cached Medicine News:Health News:Social Factors May Affect Lifespan More Than Race, Location 2Health News:Global, common approach to pharmaceutical supply chain integrity the focus of workshop 2Health News:Global, common approach to pharmaceutical supply chain integrity the focus of workshop 3Health News:Study Casts Doubt on Value of Pricey Prostate Cancer Therapy 2Health News:Study Casts Doubt on Value of Pricey Prostate Cancer Therapy 3Health News:Hutchinson Center president elected to American Academy of Art and Sciences 2Health News:Hutchinson Center president elected to American Academy of Art and Sciences 3Health News:New Method to Reveal Alzheimer's Marker Shows Promise 2Health News:Study examines adverse effects among different radiation therapies for prostate cancer 2Health News:Study examines adverse effects among different radiation therapies for prostate cancer 3
(Date:8/20/2014)... , August 20, 2014 ... Conducted in the US  KalVista Pharmaceuticals ("KalVista"), ... edema (DME), today announces that it has begun a ... plasma kallikrein inhibitor, KVD001, for the treatment of DME. ... of the Beetham Eye Institute, Joslin Diabetes Center; Harvard ...
(Date:8/19/2014)...  The Alabama Supreme Court, in a 6-3 decision on ... who mislead doctors into believing that prescription medicines the companies ... v. Wyeth, and the decision came after the Supreme Court ... year. Heninger Garrison Davis attorneys Lew Garrison and ... Danny Weeks . The decision won a ...
(Date:8/19/2014)... , Aug. 19, 2014  Northwest Biotherapeutics (NASDAQ: ... DCVax® personalized immune therapies for solid tumor cancers, announced ... last Thursday, August 14, 2014, has closed.  The three-year ... at $7.30 per share of common stock.  The investors ... purchase up to an additional 30% of these notes ...
Breaking Medicine Technology:KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 2NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 3
... Epiphany Biosciences announced,today, the initiation of a ... treatment and management of acute infectious,mononucleosis. Currently, there ... debilitating condition or any other disease caused by,the ... broad spectrum of anti-viral activity,including inhibition of viral ...
... SAN FRANCISCO, Calif., Dec. 6 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... (NYSE: PFE ), has begun a Phase 1 ... syk kinase inhibitor, R343,for the treatment of allergic asthma. ... Under the terms of the companies, 2005 collaboration ...
Cached Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3
... 1100RS Spectrophotometers are simple, ... for use in many ... educational, clinical, industrial and ... COD vial holders, Windows ...
Spectra 2000 Digital Spectrophotometer is designed for quantitative and qualitative analysis in visible range from 320 nm to 1020 nm....
... Series Spectrophotometer is truly ... UV-VIS instrumentation. The latest ... into a radically new ... and performance unprecedented in ...
... Darkfield Quebec Colony Counter allows the user ... choice of models allows for digital counting or ... over the standard lens increasing magnification to 3.0X. ... lens to be raised or lowered. The lens ...
Medicine Products: